West Virginia reaches $37 million opioid settlement with drug shipper McKesson | TribLIVE.com
U.S./World

West Virginia reaches $37 million opioid settlement with drug shipper McKesson

The Washington Post
1107968_web1_Opioids2

West Virginia and drug distributor McKesson announced a $37 million settlement of a lawsuit over the company’s role in the opioid epidemic Thursday, a record agreement for the state that leads the nation in drug overdose deaths.

McKesson, the sixth-largest company on the Fortune 500 list, admitted no wrongdoing but agreed to pay $14.5 million this year and $4.5 million annually for five years. The money will go toward state efforts to address the opioid crisis, including rehabilitation, job training and mental health programs, the company said in a statement.

The payment is the largest from any of 13 pharmaceutical wholesalers the state has been pursuing legally for years. It pushes the total recouped to $84 million, which includes previous settlments with Cardinal Health ($20 million) and AmerisourceBergen ($16 million), according to Republican Gov. Jim Justice.

Those companies and McKesson control nearly 90% of the distribution of legal painkillers in the United States.

In 2017, McKesson agreed to pay $150 million in a record-setting settlement of charges brought by federal authorities. Last year, the company pledged $100 million toward fighting the opioid crisis.

In a separate criminal case Thursday, a federal jury in Boston convicted five executives of Insys Therapeutics, including company founder John Kapoor, of racketeering charges for bribing doctors to unnecessarily prescribe the company’s powerful fentanyl spray.

The trial brought out evidence that the company paid doctors sham speaking fees and that in one case an exotic-dancer-turned-company-executive gave a doctor a lap dance to encourage him to prescribe the spray, Subsys, which is used for pain suffered by cancer patients. The woman, Sunrise Lee, was among the people convicted Thursday.

Criminal charges against drug company management are rare. But last month, federal prosecutors in New York accused two executives of the nation’s sixth-largest drug distributor, Rochester Drug Cooperative, of charges that include conspiring to distribute narcotics for nonmedical reasons. The men, one of whom has pleaded guilty and is cooperating with authorities, face 10 years to life in prison.

Hundreds of states, counties, cities and Native American tribes have filed civil suits against drug distributors, manufacturers and pharmacy chains, hoping to win compensation for the costs of grappling with the 2-decade-old drug crisis.

In a closely watched state case, Oklahoma settled in March with Purdue Pharma, the maker of OxyContin, for $270 million and is scheduled to go to trial against Johnson & Johnson and Teva Pharmaceuticals May 28.

Federal law makes distributors – which ship drugs from manufacturers to drug stores, hospitals, nursing homes and elsewhere – responsible for spotting unusual amounts, patterns or frequency of narcotic sales, which can indicate that drugs are being diverted to the black market.

Instead, McKesson distributed nearly 100 million doses of oxycodone and hydrocodone in the state — home to 1.8 million people — between 2007 and 2012, the state said. That included, for example, 1.3 million doses in Boone County, where 24,629 people lived in 201o.

In 2017, West Virginia led the nation with 57.8 drug overdose deaths per 100,000 residents, according to the Centers for Disease Control and Prevention. More than 400,000 people in the United States have died of overdoses to prescription drugs, heroin and illegal fentanyl between 1999 and 2017.

West Virginia’s attorney general, Patrick Morrisey, said in a written statement that his department “has done as much or more than any office in the country to fight this terrible epidemic, fix the failed policies of the past and bring accountability to the system.” The number of pills coming into the state has declined 35% since he took office in 2013, he said.

Categories: News | World
TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.